No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis
- 15 November 2010
- journal article
- research article
- Published by Elsevier BV in Lung Cancer
- Vol. 72 (3), 370-377
- https://doi.org/10.1016/j.lungcan.2010.10.011
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 CA131274, R01 ES011740)
This publication has 38 references indexed in Scilit:
- Predictive Effects of ERCC1 and XRCC3 SNP on Efficacy of Platinum-based Chemotherapy in Advanced NSCLC PatientsJapanese Journal of Clinical Oncology, 2010
- Meta‐analysis of genome‐wide association studies: no efficiency gain in using individual participant dataGenetic Epidemiology, 2009
- Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related PharmacogenomicsJournal of Clinical Oncology, 2009
- Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: A review of current literatureLung Cancer, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final ReportJournal of Thoracic Oncology, 2006
- Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancerCancer, 2006
- Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapyLung Cancer, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell linesAnti-Cancer Drugs, 1993